Pathway to Cures (P2C), the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), is pleased to announce the appointment of Michael Recht, MD, PhD, MBA, as chief medical and scientific advisor.

The gene therapy treatment will cease availability at the end of May 2026.

The bleeding disorders community mourns the loss of a beloved physician, researcher, and friend.

Federal Government avoids shutdown, key bleeding disorders programs funded, and State legislatures get started!

Funding for basic science, clinical studies, innovative technologies, and clinical development is available.

We believe treatment decisions should be individualized, clinically appropriate, and informed by both the available evidence and patient preferences.

The Excellence Fellowship, Judith Graham Pool Fellowship, and Sanofi-sponsored Career Development Award support multidisciplinary bleeding disorders research

The statement details reported adverse event, ongoing investigation, and plans to update the community.

The Kevin Child Scholarship is awarded annually to a student with hemophilia A or B who is either a high school senior, or someone enrolled in a vocational-technical school, college or university, or pursuing a post-secondary education.